Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| General and administrative costs | $ 966,218 | $ 121,696 |
| Advisory Fee | 6,900,000 | |
| Loss from operations | (966,218) | (7,021,696) |
| OTHER INCOME (EXPENSE) | ||
| Change in fair value of PIPE Subscription Agreements liability | (1,264,969) | |
| Interest earned on marketable securities held in Trust Account | 2,101,884 | 717,933 |
| Total other income | 836,915 | 717,933 |
| NET LOSS | $ (129,303) | $ (6,303,763) |
| Class A Ordinary Shares | ||
| OTHER INCOME (EXPENSE) | ||
| Weighted average shares outstanding (in Shares) | 23,000,000 | 7,411,111 |
| Basic net loss per ordinary share | $ 0 | $ (0.5) |
| Diluted net loss per ordinary share | $ 0 | $ (0.5) |
| Class B Ordinary Shares | ||
| OTHER INCOME (EXPENSE) | ||
| Weighted average shares outstanding (in Shares) | 5,750,000 | 5,241,667 |
| Basic net loss per ordinary share | $ 0 | $ (0.5) |
| Diluted net loss per ordinary share | $ 0 | $ (0.5) |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|